Literature DB >> 28600864

Co-utilization of hexoses by a microconsortium of sugar-specific E. coli strains.

Todd C Chappell1, Nikhil U Nair1.   

Abstract

Escherichia coli is an important commercial species used for production of biofuels, biopolymers, organic acids, sugar alcohols, and natural compounds. Processed biomass and agroindustrial byproducts serve as low-cost nutrient sources and contain a variety of hexoses available for bioconversion. However, metabolism of hexose mixtures by E. coli is inefficient due to carbon catabolite repression (CCR), where the transport and catabolic activity of one or more carbon sources is repressed and/or inhibited by the transport and catabolism of another carbon source. In this work, we developed a microconsortium of different E. coli strains, each engineered to preferentially catabolize a different hexose-glucose, galactose, or mannose. We modified the specificity and preference of carbon source using a combination of rational strain design and adaptive evolution. The modifications ultimately resulted in strains that preferentially catabolized their specified sugar. Finally, comparative analysis in galactose- and mannose-rich sugar mixtures revealed that the consortium grew faster and to higher cell densities compared to the wild-type strain. Biotechnol. Bioeng. 2017;114: 2309-2318.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  catabolite repression; hexoses; lignocellulosic biomass; metabolic engineering; microconsortium

Mesh:

Substances:

Year:  2017        PMID: 28600864     DOI: 10.1002/bit.26351

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  1 in total

1.  Catabolic Division of Labor Enhances Production of D-Lactate and Succinate From Glucose-Xylose Mixtures in Engineered Escherichia coli Co-culture Systems.

Authors:  Andrew D Flores; Hyun G Choi; Rodrigo Martinez; Moses Onyeabor; E Zeynep Ayla; Amanda Godar; Michael Machas; David R Nielsen; Xuan Wang
Journal:  Front Bioeng Biotechnol       Date:  2020-05-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.